Literature DB >> 19016911

Role of major histocompatibility complex class I-related molecules A*A5.1 allele in ulcerative colitis in Chinese patients.

Min Lü1, Bing Xia, Liuqing Ge, Yi Li, Jie Zhao, Fan Chen, Feng Zhou, Xiaolian Zhang, Jinquan Tan.   

Abstract

The major histocompatibility complex (MHC) class I-related molecules A (MICA) is a stress-inducible cell surface antigen that is recognized by intestinal epithelial Vdelta1 gammadelta T cells, natural killer (NK) cells and CD8(+) T cells with NKG2D receptor participating in the immunological reaction in the intestinal mucosa. The present study aimed to investigate the functions of the MICA*A5.1 allele in the development of ulcerative colitis (UC) in the Chinese population. The microsatellite polymorphisms of MICA were genotyped in 124 unrelated Chinese patients with UC and 172 ethnically matched healthy controls using a semiautomatic fluorescently labelled polymerase chain reaction. MICA*A5.1-expressing Raji cells were generated by gene transfection. Cytotoxicity of NK cells to Raji cells expressing different MICA molecules was detected using the lactate dehydrogenase method. Soluble MICA in the culture supernatant was detected by enzyme-linked immunosorbent assay. The frequency of MICA*A5.1 was significantly higher in UC patients compared with the healthy controls (29.0% versus 17.4%, P = 0.001, corrected P = 0.005, OR = 1.936, 95% CI 1.310-2.863) and the frequency of a MICA*A5.1/A5.1 homozygous genotype was increased in UC patients (18.5% versus 7% in healthy controls, P = 0.0032, corrected P = 0.048, OR = 3.036, 95% CI 1.447-6.372). Raji cells with MICA*A5.1 expression produced more soluble MICA (t = 5.75, P < 0.01) than Raji cells with full-length MICA expression in culture supernatant. Raji cells with MICA*A5.1 expression were more resistant to killing by NK cells than Raji cells with full-length MICA expression. The MICA*A5.1 allele and MICA*A5.1/A5.1 genotype are significantly associated with Chinese UC patients in central China. MICA*A5.1 may play a role in the development of UC by producing more soluble MICA and resistance to NK cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016911      PMCID: PMC2753932          DOI: 10.1111/j.1365-2567.2008.02953.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

1.  Expression of nonclassical class I molecules by intestinal epithelial cells.

Authors:  Lilani Perera; Ling Shao; Anjlee Patel; Kelly Evans; Bertrand Meresse; Richard Blumberg; Daniel Geraghty; Veronika Groh; Thomas Spies; Bana Jabri; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

Review 2.  Familial occurrence and inheritance studies in inflammatory bowel disease.

Authors:  V Binder; M Orholm
Journal:  Neth J Med       Date:  1996-02       Impact factor: 1.422

3.  Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease.

Authors:  N Mizuki; M Ota; M Kimura; S Ohno; H Ando; Y Katsuyama; M Yamazaki; K Watanabe; K Goto; S Nakamura; S Bahram; H Inoko
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells.

Authors:  V Groh; A Steinle; S Bauer; T Spies
Journal:  Science       Date:  1998-03-13       Impact factor: 47.728

Review 5.  The MIC gene family.

Authors:  S Bahram; T Spies
Journal:  Res Immunol       Date:  1996-06

6.  Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian.

Authors:  M Ota; Y Katsuyama; N Mizuki; H Ando; K Furihata; S Ono; P Pivetti-Pezzi; K F Tabbara; G D Palimeris; B Nikbin; F Davatchi; H Chams; Z Geng; S Bahram; H Inoko
Journal:  Tissue Antigens       Date:  1997-05

7.  New major histocompatibility complex genes.

Authors:  B Marshall; C Leelayuwat; M A Degli-Esposti; M Pinelli; L J Abraham; R L Dawkins
Journal:  Hum Immunol       Date:  1993-09       Impact factor: 2.850

8.  Allelic repertoire of the human MHC class I MICA gene.

Authors:  N Fodil; L Laloux; V Wanner; P Pellet; G Hauptmann; N Mizuki; H Inoko; T Spies; I Theodorou; S Bahram
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

9.  MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes.

Authors:  N W Zwirner; M A Fernández-Viña; P Stastny
Journal:  Immunogenetics       Date:  1998       Impact factor: 2.846

10.  A new polymorphic and multicopy MHC gene family related to nonmammalian class I.

Authors:  C Leelayuwat; D C Townend; M A Degli-Esposti; L J Abraham; R L Dawkins
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

View more
  11 in total

Review 1.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

Review 2.  Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.

Authors:  Manuel Muro; Ruth López-Hernández; Anna Mrowiec
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

3.  A genetic variant in the placenta-derived MHC class I chain-related gene A increases the risk of preterm birth in a Chinese population.

Authors:  Junjiao Song; Jing Li; Han Liu; Yuexin Gan; Yang Sun; Min Yu; Yongjun Zhang; Fei Luo; Ying Tian; Weiye Wang; Jun Zhang; Julian Little; Haidong Cheng; Dan Chen
Journal:  Hum Genet       Date:  2017-09-01       Impact factor: 4.132

4.  A selective role of NKG2D in inflammatory and autoimmune diseases.

Authors:  Nadia Guerra; Kathleen Pestal; Tiffany Juarez; Jennifer Beck; Karen Tkach; Lin Wang; David H Raulet
Journal:  Clin Immunol       Date:  2013-09-14       Impact factor: 3.969

5.  MICA*A4 protects against ulcerative colitis, whereas MICA*A5.1 is associated with abscess formation and age of onset.

Authors:  A Martinez-Chamorro; A Moreno; M Gómez-García; M J Cabello; J Martin; M Á Lopez-Nevot
Journal:  Clin Exp Immunol       Date:  2016-04-05       Impact factor: 4.330

6.  Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.

Authors:  Vinod Kumar; Paulisally Hau Yi Lo; Hiromi Sawai; Naoya Kato; Atsushi Takahashi; Zhenzhong Deng; Yuji Urabe; Hamdi Mbarek; Katsushi Tokunaga; Yasuhito Tanaka; Masaya Sugiyama; Masashi Mizokami; Ryosuke Muroyama; Ryosuke Tateishi; Masao Omata; Kazuhiko Koike; Chizu Tanikawa; Naoyuki Kamatani; Michiaki Kubo; Yusuke Nakamura; Koichi Matsuda
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

7.  A variant upstream of HLA-DRB1 and multiple variants in MICA influence susceptibility to cervical cancer in a Swedish population.

Authors:  Dan Chen; Joanna Hammer; David Lindquist; Annika Idahl; Ulf Gyllensten
Journal:  Cancer Med       Date:  2014-01-07       Impact factor: 4.452

8.  Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases.

Authors:  Qingwen Wang; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2015-11-24

Review 9.  Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.

Authors:  Raphael Carapito; Ismail Aouadi; Wassila Ilias; Seiamak Bahram
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561

10.  The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.

Authors:  Antje Isernhagen; Daniela Schilling; Sebastian Monecke; Pranali Shah; Leslie Elsner; Lutz Walter; Gabriele Multhoff; Ralf Dressel
Journal:  Immunogenetics       Date:  2015-11-19       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.